{
    "clinical_study": {
        "@rank": "127738", 
        "arm_group": [
            {
                "arm_group_label": "Aspirin discontinuers; Aspirin non-discontinuers", 
                "description": "Patients on low dose ASA for secondary prevention that discontinue aspirin and those not discontinuing aspirin"
            }, 
            {
                "arm_group_label": "Drug", 
                "description": "PPI continuous use; No PPI use"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is conducted in a cohort of low dose aspirin (ASA) users previously ascertained\n      .The aims of the post hoc analyses  are:\n\n      To estimate the one year risk of discontinuation of use of low-dose ASA associated to PPI\n      concomitant use versus non-use, crude and adjusted by confounding.\n\n      To estimate the one year risk of discontinuation of use of low-dose ASA associated to PPI\n      concomitant use stratified by age and sex.\n\n      To evaluate other predictors of discontinuation of low-dose ASA during the first year of ASA\n      therapy."
        }, 
        "brief_title": "Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cardiovascular Prevention", 
        "detailed_description": {
            "textblock": "Assessment of low-dose ASA discontinuation risk associated with concomitant PPI use during\n      the first year of ASA therapy for secondary prevention"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged 50-84 years in 2000-2007.\n\n          -  Patients with first prescription of low dose ASA ( see study population description).\n\n          -  Patients were required to have been enrolled with their primary care practitioner\n             (PCP) for at least 2 years and to have a computerized prescription history of at\n             least 1 year before the start of the study.\n\n        Exclusion Criteria:\n\n          -  Patients aged below age 50 and 85 years and above ( see study population\n             description).\n\n          -  Patients with a diagnosis of cancer, alcohol abuse or alcohol-related disease.\n\n          -  Incomplete data recording in THIN."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "84 Years", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "This is a pharmacoepidemiology study using data from The Health Improvement Network (THIN)\n        primary care database in the UK. Patients aged 50-84 years with evidence of ischemic heart\n        disease or cerebrovascular disease, who were new users of low-dose ASA (75-300 mg/day) and\n        who had received at least two low-dose ASA prescriptions for the secondary prevention of\n        cardiovascular disease or cerebrovascular disease between 2000 and 2007 were identified\n        from THIN.  ."
            }
        }, 
        "enrollment": {
            "#text": "35604", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01888575", 
            "org_study_id": "D5040N00008"
        }, 
        "intervention": {
            "arm_group_label": "Aspirin discontinuers; Aspirin non-discontinuers", 
            "description": "PPI continuous use; No PPI usePPI", 
            "intervention_name": "Risk of low dose aspirin discontinuation", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Discontinuation of low dose ASA,", 
            "Secondary cardiovascular prevention,", 
            "Acid-suppressing drugs,", 
            "Gastrointestinal risk,", 
            "Epidemiology"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "link": [
            {
                "description": "D5040N00008_CSP.pdf", 
                "url": "http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=463&filename=D5040N00008_CSP.pdf"
            }, 
            {
                "description": "CSR Synopsis D5040N00008", 
                "url": "http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=463&filename=CSR_Synopsis_D5040N00008_25_04_2014.pdf"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain"
                }, 
                "name": "Research Site"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "2", 
        "official_title": "Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy for Secondary Prevention", 
        "overall_official": {
            "affiliation": "CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )", 
            "last_name": "Luis A Garcia Rodriguez, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": ": Not applicable", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Risk (hazard ratios) of low dose ASA discontinuation associated with continuous PPI use vs. non-use.", 
                "measure": "Risk of low dose ASA discontinuation associated with continuous PPI use vs.non-use", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year."
            }, 
            {
                "description": "Risk ( hazard ratios) of low dose ASA discontinuation associated with baseline gastrointestinal risk category( high risk versus low risk).", 
                "measure": "Risk of  low dose ASA discontinuation associated with baseline gastrointestinal risk category ( high risk versus low risk)", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }
        ], 
        "reference": [
            {
                "PMID": "21811460", 
                "citation": "Cea Soriano L, Rodr\u00edguez LA. Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. Front Pharmacol. 2010;1:126. doi: 10.3389/fphar.2010.00126. Epub 2010 Oct 14."
            }, 
            {
                "PMID": "21270415", 
                "citation": "Garc\u00eda Rodr\u00edguez LA, Cea Soriano L, Hill C, Johansson S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology. 2011 Feb 22;76(8):740-6. doi: 10.1212/WNL.0b013e31820d62b5. Epub 2011 Jan 26."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01888575"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}